Max Planck Institute for Experimental Medicine
Scientists at the Max Planck Institute for Multidisciplinary Sciences (previously: Max Planck Institute for Experimental Medicine; merged with the Max Planck Institute for Biophysical Chemistry from 1.01.2022) conduct basic medical research in the neurosciences and oncology. In line with the Institute's mission, "from the lab bench to the hospital bed", fundamental work in the neurosciences and clinical studies on new therapeutic approaches are combined. The scientists’ objective is to understand molecular and cellular processes in the nervous system and other organs, as well as their pathological disorders. The scientists’ findings form the basis for new diagnostic and therapeutic approaches that can be applied to a range of psychiatric diseases such as autism and schizophrenia, to neurological disorders like multiple sclerosis and strokes, or to cancer. For example, scientists from the Institute study the development of the brain and the molecular basis of signal transmission between nerve cells. Furthermore, their research focuses on the function of channel proteins in cell membranes and their role in the development of cancer. Numerous research groups at the Institute work on turning the findings obtained at the Institute into clinical applications.
Phone: +49 551 3899-0
Fax: +49 551 3899-389